Patent intelligence · Companies
Company patent strength
Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead — toggle to foreign applicants to see who is entering the Indian market.
Free to browse the ranking. Sign into open a filer's full profile — inventors, filing trend and quality index. See how we rank.
Why this page exists — and how to read it
Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.
- Investors
- High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
- Founders & operators
- These are the incumbents and potential acquirers in your space — open a filer to see the walls you'd build against.
- Corporate & R&D
- Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.
💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.
3,207 foreign filers with 5+ patents · page 31
| # | Filer | Patents↓ | Granted↓ | Lapsed↓ | Pending↓ | Active |
|---|---|---|---|---|---|---|
| 1501 | TELECOM ITALIA | 10 | 110% | 0 | 9 | 2021–2026 |
| 1502 | THYSSENKRUPP STEEL EUROPE | 10 | 330% | 0 | 7 | 2022–2024 |
| 1503 | TOYO ALUMINIUM | 10 | 110% | 1 | 8 | 2022–2025 |
| 1504 | TRANSLATE BIO | 10 | 00% | 1 | 9 | 2022–2024 |
| 1505 | TRUE MANUFACTURING | 10 | 00% | 4 | 6 | 2022–2025 |
| 1506 | TUOJIE BIOTECH SHANGHAI | 10 | 00% | 0 | 10 | 2023–2025 |
| 1507 | TWIST BIOSCIENCE | 10 | 00% | 3 | 7 | 2022–2024 |
| 1508 | UPL DO BRASIL INDUSTRIA E COMERCIO DE INSUMOS AGROPECUARIOS | 10 | 550% | 1 | 4 | 2019–2024 |
| 1509 | USUI | 10 | 00% | 0 | 10 | 2022–2026 |
| 1510 | VIDEOJET TECHNOLOGIES | 10 | 00% | 0 | 10 | 2023–2025 |
| 1511 | VIEW OPERATING | 10 | 00% | 0 | 10 | 2025–2026 |
| 1512 | YAKULT HONSHA | 10 | 00% | 0 | 10 | 2022–2025 |
| 1513 | YASKAWA DENKI | 10 | 440% | 0 | 6 | 2021–2026 |
| 1514 | ABS GLOBAL | 9 | 111.1% | 1 | 7 | 2020–2025 |
| 1515 | ACUITAS THERAPEUTICS | 9 | 00% | 1 | 8 | 2022–2026 |
| 1516 | ADISSEO FRANCE S | 9 | 111.1% | 0 | 8 | 2022–2026 |
| 1517 | ADS THERAPEUTICS | 9 | 111.1% | 0 | 8 | 2022–2026 |
| 1518 | ADVANSIX RESINS CHEMICALS | 9 | 777.8% | 1 | 1 | 2022–2024 |
| 1519 | ADVERUM BIOTECHNOLOGIES | 9 | 111.1% | 2 | 6 | 2019–2026 |
| 1520 | AIR WATER | 9 | 00% | 0 | 9 | 2024–2026 |
| 1521 | AIRNOV | 9 | 222.2% | 0 | 7 | 2022–2026 |
| 1522 | ALBANY ENGINEERED COMPOSITES | 9 | 00% | 3 | 6 | 2022–2023 |
| 1523 | ALBEA SERVICES | 9 | 111.1% | 0 | 8 | 2022–2026 |
| 1524 | ALCOA USA | 9 | 222.2% | 1 | 6 | 2022–2025 |
| 1525 | ALPHA ASSEMBLY SOLUTIONS | 9 | 00% | 0 | 9 | 2022–2026 |
| 1526 | ALPHA TAU MEDICAL | 9 | 111.1% | 0 | 8 | 2022–2025 |
| 1527 | AMOGREENTECH | 9 | 222.2% | 0 | 7 | 2022–2025 |
| 1528 | ANNIKKI | 9 | 00% | 0 | 9 | 2022–2026 |
| 1529 | ANTENGENE BIOLOGICS | 9 | 00% | 0 | 9 | 2023–2025 |
| 1530 | ARBUTUS BIOPHARMA | 9 | 00% | 1 | 8 | 2022–2025 |
| 1531 | ARCUTIS BIOTHERAPEUTICS | 9 | 00% | 2 | 7 | 2022–2025 |
| 1532 | ARLA FOODS AMBA | 9 | 00% | 0 | 9 | 2022–2025 |
| 1533 | AUTOLIV ASP | 9 | 111.1% | 0 | 8 | 2022–2025 |
| 1534 | BASF AGRICULTURAL SOLUTIONS US | 9 | 00% | 0 | 9 | 2025–2026 |
| 1535 | BASF AGRO | 9 | 111.1% | 0 | 8 | 2022–2025 |
| 1536 | BASF AGRO TRADEMARKS | 9 | 111.1% | 6 | 2 | 2021–2024 |
| 1537 | BAYA SYSTEMS | 9 | 00% | 0 | 9 | 2024–2024 |
| 1538 | BEIERSDORF | 9 | 00% | 0 | 9 | 2024–2026 |
| 1539 | BETHEL AUTOMOTIVE SAFETY SYSTEMS | 9 | 111.1% | 0 | 8 | 2023–2025 |
| 1540 | BIOCRYST PHARMACEUTICALS | 9 | 222.2% | 1 | 6 | 2022–2026 |
| 1541 | BIOND BIOLOGICS | 9 | 00% | 3 | 6 | 2022–2024 |
| 1542 | BIOTYX MEDICAL SHENZHEN | 9 | 00% | 0 | 9 | 2022–2026 |
| 1543 | BLOSSOMHILL THERAPEUTICS | 9 | 00% | 0 | 9 | 2022–2026 |
| 1544 | BRIGHTSEED | 9 | 00% | 2 | 7 | 2022–2025 |
| 1545 | BUCKMAN LABORATORIES INTERNATIONAL | 9 | 111.1% | 2 | 6 | 2022–2026 |
| 1546 | C I TAKIRON | 9 | 444.4% | 0 | 5 | 2022–2025 |
| 1547 | CAIHONG DISPLAY DEVICES | 9 | 00% | 0 | 9 | 2025–2025 |
| 1548 | CAVAGNA GROUP | 9 | 00% | 0 | 9 | 2022–2025 |
| 1549 | CELLIGENCE INTERNATIONAL | 9 | 222.2% | 0 | 7 | 2022–2025 |
| 1550 | CENERGIST | 9 | 555.6% | 0 | 4 | 2022–2024 |
Educational institutes are excluded — see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →
Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy — directional, not advice; see methodology. Read the ranking methodology →